- Advertisement -

Neurodegenerative Treatments Build to a Tipping Point

Neurodegenerative diseases represent the greatest therapeutic challenge of our time. Worldwide, an estimated 60 million people suffer from neurodegenerative diseases, which impair the function...

Innovative probe could deepen the understanding of key cellular messenger and lead to new drug discoveries

A ground-breaking study by Loughborough University and the University of Oxford has led to the development of a small molecule probe that could deepen...

A study investigating genetic mechanisms underlying resistance to leishmaniasis

The study was conducted in Brazil and mapped the genes that are activated when mice resistant to Leishmania are infected. Molecules involved in the...

Elsevier partners with American College of Medical Genetics and Genomics to...

Collaboration signifies strong commitment by all stakeholders to maintain the journal’s high standards and expand its global prominence Credit: ACMG

Resins Address Downstream Purification Concerns

The demand for safe and efficacious biologics has accelerated exponentially in the past several years due to the tremendous success of some of the...

Gender assumptions harm progress on climate adaption and resilience

Credit: Jacqui Lau. Scientists say outdated assumptions around gender continue to hinder effective and fair policymaking and...

Breakthrough CAR-T Therapy Shows Promising Outcomes in Patients with Refractory Lymphoma

A groundbreaking advancement in the fight against refractory CD30-positive lymphomas has emerged from researchers at the Sant Pau Research Institute (IR Sant Pau), in...

Complete Genomics and Velsera Partner to Integrate Sequencing and Analysis Platforms

Complete Genomics and Velsera are collaborating to deliver an end-to-end genetic testing solution that integrates DNBSEQ sequencing technology with Velsera’s Clinical Genomics Workspace (CGW)...

Breakthrough CAR-T Therapy Shows Promising Outcomes in Patients with Refractory Lymphoma

A groundbreaking advancement in the fight against refractory CD30-positive lymphomas has emerged from researchers at the Sant Pau Research Institute (IR Sant Pau), in...

Complete Genomics and Velsera Partner to Integrate Sequencing and Analysis Platforms

Complete Genomics and Velsera are collaborating to deliver an end-to-end genetic testing solution that integrates DNBSEQ sequencing technology with Velsera’s Clinical Genomics Workspace (CGW)...

Integrating Exercise and Rehabilitation into Breast Cancer Care: A New Frontier

A groundbreaking randomized controlled trial has recently illuminated the promising potential of a pioneering program designed to systematically connect breast cancer patients with tailored...

more new items

Breakthrough CAR-T Therapy Shows Promising Outcomes in Patients with Refractory Lymphoma

A groundbreaking advancement in the fight against refractory CD30-positive lymphomas has emerged from researchers at the Sant Pau Research Institute (IR Sant Pau), in...

Complete Genomics and Velsera Partner to Integrate Sequencing and Analysis Platforms

Complete Genomics and Velsera are collaborating to deliver an end-to-end genetic testing solution that integrates DNBSEQ sequencing technology with Velsera’s Clinical Genomics Workspace (CGW)...

Integrating Exercise and Rehabilitation into Breast Cancer Care: A New Frontier

A groundbreaking randomized controlled trial has recently illuminated the promising potential of a pioneering program designed to systematically connect breast cancer patients with tailored...